Skip to content
OpenCapital
Get started

Medline, Inc. MDLN International — Net Sales

Similar metrics at other companies

AngioDynamics logo
ANGOInternational — Net Sales
$11.15M+4.5%
MiniMed Group logo
MMEDInternational — Net Sales
$548M+20.2%
Olaplex Holdings, Inc. logo
OLPXInternational — Net Sales
$51.93M+8.6%
The Vita Coco Company, Inc. logo
COCOInternational — Net Sales
$31.6M+72.5%
Bioventus logo
BVSInternational — Total Net Sales
$15.64M+17.1%
Baxter International logo
BAXInternational — Net Sales
$1.27B+11.5%

Other financials

Income statement

See full
Revenue$7.4B+10.7%
Gross profit$1.8B+0.9%
Operating income$422.0M-26.1%
Net income$239.0M-25.1%
EPS (diluted)$0.16—

Balance sheet

See full
Cash & equivalents$2.2B+166%
Total debt$12.6B—
Total equity$11.3B—
Total assets$39.0B—

Cash flow

See full
Operating cash flow$412.0M-39.6%
CapEx$96.0M-2.0%
Free cash flow$316.0M-45.9%

Valuation

See full
Market cap$32.87B+5.7%
Enterprise value$43.19B—
P/E39.1×—
P/S1.2×—

Profitability

See full
Gross margin27.4%+1.5pp
Operating margin8.5%+2.3pp
Net margin4.6%+2.7pp
FCF margin6.4%+0.5pp

Returns & leverage

See full
Return on equity7.7%—
Debt / equity1.1×—
Current ratio4.4×—

Where this comes from

Reported directly by Medline, Inc. in its filing.

Tagged under the XBRL concept us-gaap:Revenues.

The official record: Medline, Inc. ’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Medline, Inc. 's international — net sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Medline, Inc. 's international — net sales?
Medline, Inc. (MDLN) reported international — net sales of $495M in Q1 2026.
How has Medline, Inc. 's international — net sales changed year-over-year?
Medline, Inc. 's international — net sales increased by 10.0% year-over-year, from $450M to $495M.
What does international — net sales mean?
This metric represents the total revenue generated from the sale of medical-surgical products and supply chain solutions within geographic markets outside of the company's primary domestic region. It reflects the company's ability to capture market share, execute international expansion strategies, and meet demand in global healthcare settings. Growth in this metric indicates successful penetration into foreign healthcare systems and effective management of international distribution channels.